Liy-Salmeron Gustavo, Meneses Alfredo
Departamento de Farmacobiología, CINVESTAV-IPN, Tenorios 235, Granjas Coapa 14330, México.
Brain Res. 2007 May 25;1147:140-7. doi: 10.1016/j.brainres.2007.02.007. Epub 2007 Feb 8.
It was previously reported that brain areas containing serotonin (5-hydroxytryptamine, 5-HT) receptors mediate memory consolidation as well as short (STM)- and long-term memory (LTM). Here the effects of systemic and intrahippocampal administration of 5-HT agonists and antagonists on an autoshaping learning task were explored, which requires hippocampal translation and transduction as well as 5-HT receptors expression. As previously reported ketamine (glutamatergic antagonist) and two well-known amnesic drugs, scopolamine (cholinergic antagonist) and dizocilpine (NMDA antagonist) impaired STM but not LTM; dizocilpine even improved the latter. Since ketamine produces hallucinations and impairs memory in humans, we address the question if well-known antipsychotic haloperidol and clozapine might affect STM deficit. Indeed, systemic administration of clozapine<haloperidol reversed the ketamine-STM deficit. Considering that clozapine and haloperidol are antagonists for dopaminergic D2 and 5-HT(1A/2A/6/7) receptors, systemic and intrahippocampal administration of 5-HT drugs were further explored. The ketamine STM-induced deficit was blocked by 8-OHDPAT (5-HT(1A/7) agonist) and SB-399885 (a 5-HT(6) antagonist) but not by 5-HT(1B), 5-HT(2) and 5-HT(7) antagonists, thus implicating 5-HT(1A/7) and 5-HT(6) receptors. These data also suggest that ketamine (at 10 mg/kg) represents a reliable pharmacological tool to explore memory deficits related to hippocampus and schizophrenia.
先前有报道称,含有血清素(5-羟色胺,5-HT)受体的脑区介导记忆巩固以及短期(STM)和长期记忆(LTM)。在此,研究了全身和海马内给予5-HT激动剂和拮抗剂对自动塑造学习任务的影响,该任务需要海马的翻译和转导以及5-HT受体表达。如先前报道,氯胺酮(谷氨酸能拮抗剂)以及两种著名的致遗忘药物东莨菪碱(胆碱能拮抗剂)和地卓西平(NMDA拮抗剂)损害STM但不损害LTM;地卓西平甚至改善了后者。由于氯胺酮会导致人类产生幻觉并损害记忆,我们探讨了著名的抗精神病药物氟哌啶醇和氯氮平是否可能影响STM缺陷。事实上,全身给予氯氮平<氟哌啶醇可逆转氯胺酮诱导的STM缺陷。鉴于氯氮平和氟哌啶醇是多巴胺能D2和5-HT(1A/2A/6/7)受体的拮抗剂,进一步研究了全身和海马内给予5-HT药物的情况。氯胺酮诱导的STM缺陷被8-OHDPAT(5-HT(1A/7)激动剂)和SB-399885(一种5-HT(6)拮抗剂)阻断,但未被5-HT(1B)、5-HT(2)和5-HT(7)拮抗剂阻断,因此表明涉及5-HT(1A/7)和5-HT(6)受体。这些数据还表明,氯胺酮(10mg/kg)是探索与海马体和精神分裂症相关的记忆缺陷的可靠药理学工具。